Androgen receptor coregulator CTBP1-AS is associated with polycystic ovary syndrome in Chinese women: A preliminary study

Reproductive Sciences

Volumn 22, Issue 7, 2015, Pages 829-837

  Liu, Zhenteng ^a,b   Hao, Cuifang ^b   Song, Dehua ^b   Zhang, Ning ^b   Bao, Hongchu ^b   Qu, Qinglan ^b  

^a QINGDAO UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

androgen receptor; CTBP1 AS; hyperandrogenism; lncRNA; polycystic ovary syndrome

Indexed keywords

ANDROGEN RECEPTOR; C TERMINAL BINDING PROTEIN 1 ANTISENSE; LONG UNTRANSLATED RNA; TESTOSTERONE; UNCLASSIFIED DRUG; ALCOHOL DEHYDROGENASE; C-TERMINAL BINDING PROTEIN; DNA BINDING PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARBOXY TERMINAL SEQUENCE; CELL ISOLATION; CHINESE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HIRSUTISM; HORMONE DETERMINATION; HUMAN; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; RNA ISOLATION; ASIAN CONTINENTAL ANCESTRY GROUP; BIOSYNTHESIS; GENETICS; METABOLISM; PHYSIOLOGY;

ADULT; ALCOHOL OXIDOREDUCTASES; ASIAN CONTINENTAL ANCESTRY GROUP; DNA-BINDING PROTEINS; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; RECEPTORS, ANDROGEN;

EID: 84936090124     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719114565037     Document Type: Article

References (50)

1. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R,. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011; 7 (4): 219-231.
2. Sung YA, Oh JY, Chung H, Lee H,. Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome. Fertil Steril. 2014; 101 (3): 840-845.
3. Azziz R, Carmina E, Dewailly D,. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006; 91 (11): 4237-4245.
4. Gelmann EP,. Molecular biology of the androgen receptor. J Clin Oncol. 2002; 20 (13): 3001-3015.
5. Blank SK, McCartney CR, Helm KD, Marshall JC,. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med. 2007; 25 (5): 352-359.
6. Sen A, Hammes SR,. Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol. 2010; 24 (7): 1393-1403.
7. Walters KA, Middleton LJ, Joseph SR,. Targeted loss of androgen receptor signaling in murine granulosa cells of preantral and antral follicles causes female subfertility. Biol Reprod. 2012; 87 (6): 151.
8. Corbould A,. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol. 2007; 192 (3): 585-594.
9. Allemand MC, Irving BA, Asmann YW,. Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes - a potential model for PCOS-related insulin resistance. PLoS One. 2009; 4 (1): e4274.
10. Schuring AN, Welp A, Gromoll J,. Role of the CAG repeat polymorphism of the androgen receptor gene in polycystic ovary syndrome (PCOS). Exp Clin Endocrinol Diabetes. 2012; 120 (2): 73-79.
11. Shah NA, Antoine HJ, Pall M, Taylor KD, Azziz R, Goodarzi MO,. Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metab. 2008; 93 (5): 1939-1945.
12. Vottero A, Stratakis CA, Ghizzoni L, Longui CA, Karl M, Chrousos GP,. Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation. J Clin Endocrinol Metab. 1999; 84 (3): 1091-1095.
13. Mifsud A, Ramirez S, Yong EL,. Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. J Clin Endocrinol Metab. 2000; 85 (9): 3484-3488.
14. Peng CY, Xie HJ, Guo ZF,. The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis. J Assist Reprod Genet. 2014; 31 (9): 1211-1219.
15. Dasgupta S, Sirisha PV, Neelaveni K,. Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with Polycystic Ovary Syndrome. PLoS One. 2010; 5 (8): e12401.
16. Ferk P, Perme MP, Teran N, Gersak K,. Androgen receptor gene (CAG)n polymorphism in patients with polycystic ovary syndrome. Fertil Steril. 2008; 90 (3): 860-863.
17. Jaaskelainen J, Korhonen S, Voutilainen R, Hippelainen M, Heinonen S,. Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome. Fertil Steril. 2005; 83 (6): 1724-1728.
18. Liu Q, Hong J, Cui B,. Androgen receptor gene CAG(n) trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome. Endocrine. 2008; 33 (2): 165-170.
19. Skrgatic L, Baldani DP, Cerne JZ, Ferk P, Gersak K,. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels. J Steroid Biochem Mol Biol. 2012; 128 (3-5): 107-112.
20. Rajender S, Carlus SJ, Bansal SK,. Androgen receptor CAG repeats length polymorphism and the risk of polycystic ovarian syndrome (PCOS). PLoS One. 2013; 8 (10): e75709.
21. Kim JJ, Choung SH, Choi YM, Yoon SH, Kim SH, Moon SY,. Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. Fertil Steril. 2008; 90 (6): 2318-2323.
22. Hickey T, Chandy A, Norman RJ,. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87 (1): 161-165.
23. Heemers HV, Tindall DJ,. Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev. 2007; 28 (7): 778-808.
24. Ravindranathan P, Lee TK, Yang L,. Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer. Nat Commun. 2013; 4: 1923.
25. Urbanucci A, Waltering KK, Suikki HE, Helenius MA, Visakorpi T,. Androgen regulation of the androgen receptor coregulators. BMC Cancer. 2008; 8: 219.
26. Vija L, Meduri G, Comperat E,. Expression and characterization of androgen receptor coregulators, SRC-2 and HBO1, during human testis ontogenesis and in androgen signaling deficient patients. Mol Cell Endocrinol. 2013; 375 (1-2): 140-148.
27. Takayama K, Horie-Inoue K, Katayama S,. Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer. EMBO J. 2013; 32 (12): 1665-1680.
28. Takayama K, Tsutsumi S, Katayama S,. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells. Oncogene. 2011; 30 (5): 619-630.
29. Sung YY, Cheung E,. Antisense now makes sense: dual modulation of androgen-dependent transcription by CTBP1-AS. EMBO J. 2013; 32 (12): 1653-1654.
30. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19 (1): 41-47.
31. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29 (9): e45.
32. Schmittgen TD, Livak KJ,. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3 (6): 1101-1108.
33. Dewailly D, Catteau-Jonard S, Reyss AC, Leroy M, Pigny P,. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab. 2006; 91 (10): 3922-3927.
34. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO,. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004; 89 (6): 2745-2749.
35. McEwan IJ, McGuinness D, Hay CW, Millar RP, Saunders PT, Fraser HM,. Identification of androgen receptor phosphorylation in the primate ovary in vivo. Reproduction. 2010; 140 (1): 93-104.
36. Xia Y, Che Y, Zhang X,. Polymorphic CAG repeat in the androgen receptor gene in polycystic ovary syndrome patients. Mol Med Rep. 2012; 5 (5): 1330-1334.
37. Wang R, Goodarzi MO, Xiong T, Wang D, Azziz R, Zhang H,. Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis. Mol Hum Reprod. 2012; 18 (10): 498-509.
38. Lee HJ, Chang C,. Recent advances in androgen receptor action. Cell Mol Life Sci. 2003; 60 (8): 1613-1622.
39. Weichenhan D, Plass C,. The evolving epigenome. Hum Mol Genet. 2013; 22 (R1): R1-R6.
40. Yeh S, Chang C,. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci U S A. 1996; 93 (11): 5517-5521.
41. Ibanez L, Ong KK, Mongan N,. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J Clin Endocrinol Metab. 2003; 88 (7): 3333-3338.
42. Hsiao PW, Lin DL, Nakao R, Chang C,. The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. J Biol Chem. 1999; 274 (29): 20229-20234.
43. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL,. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab. 1997; 82 (11): 3777-3782.
44. McAbee MD, Doncarlos LL,. Estrogen, but not androgens, regulates androgen receptor messenger ribonucleic acid expression in the developing male rat forebrain. Endocrinology. 1999; 140 (8): 3674-3681.
45. Gupta C,. Modulation of androgen receptor (AR)-mediated transcriptional activity by EGF in the developing mouse reproductive tract primary cells. Mol Cell Endocrinol. 1999; 152 (1-2): 169-178.
46. Van Nieuwerburgh F, Stoop D, Cabri P, Dhont M, Deforce D, De Sutter P,. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome. Gynecol Endocrinol. 2008; 24 (12): 669-673.
47. Yang L, Lin C, Jin C,. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs. Nature. 2013; 500 (7464): 598-602.
48. Moran C, Arriaga M, Rodriguez G, Moran S,. Obesity differentially affects phenotypes of polycystic ovary syndrome. Int J Endocrinol. 2012; 2012: 317241.
49. Spencer JB, Klein M, Kumar A, Azziz R,. The age-associated decline of androgens in reproductive age and menopausal Black and White women. J Clin Endocrinol Metab. 2007; 92 (12): 4730-4733.
50. Diamanti-Kandarakis E, Dunaif A,. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012; 33 (6): 981-1030.